Functional Brands Inc. Files S-1 Registration

Ticker: MEHA · Form: S-1 · Filed: Jan 8, 2025 · CIK: 1837254

Functional Brands INC. S-1 Filing Summary
FieldDetail
CompanyFunctional Brands INC. (MEHA)
Form TypeS-1
Filed DateJan 8, 2025
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0.00001, $4.00, $5.00, $4.50
Sentimentneutral

Sentiment: neutral

Topics: ipo, registration-statement, sec-filing

TL;DR

Functional Brands (fka HT Naturals) filed S-1. IPO incoming?

AI Summary

Functional Brands Inc., formerly HT Naturals Inc., filed an S-1 registration statement on January 8, 2025. The company, incorporated in Delaware, operates in the medicinal chemicals & botanical products sector. Its principal executive offices are located at 6400 SW Rosewood Street, Lake Oswego, Oregon.

Why It Matters

This S-1 filing indicates Functional Brands Inc. is preparing to offer its securities to the public, which could lead to increased liquidity and capital for the company's operations.

Risk Assessment

Risk Level: medium — As an S-1 filing, it represents a company seeking to go public, which inherently carries risks associated with market volatility and business execution.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this S-1 filing?

The S-1 filing is a registration statement required by the SEC for companies planning to offer securities to the public, indicating Functional Brands Inc. is preparing for an initial public offering (IPO) or other public sale of stock.

When was this S-1 filing submitted?

The S-1 filing was submitted to the SEC on January 8, 2025.

What was Functional Brands Inc. previously known as?

Functional Brands Inc. was formerly known as HT Naturals Inc., with a name change occurring on December 18, 2020.

Where are Functional Brands Inc.'s principal executive offices located?

The company's principal executive offices are located at 6400 SW Rosewood Street, Lake Oswego, Oregon, 97035.

What industry does Functional Brands Inc. operate in?

Functional Brands Inc. operates in the 'Medicinal Chemicals & Botanical Products' sector, as indicated by its Standard Industrial Classification (SIC) code 2833.

Filing Stats: 4,411 words · 18 min read · ~15 pages · Grade level 14.6 · Accepted 2025-01-08 17:01:13

Key Financial Figures

Filing Documents

Risk Factors

Risk Factors 13 Cautionary Statement Regarding

Forward-Looking Statements

Forward-Looking Statements 35

Use of Proceeds

Use of Proceeds 36 Dividend Policy 37 Capitalization 37

Dilution

Dilution 38 Management’s Discussion and Analysis of Financial Condition and Results of Operations 39

Business

Business 49 Management 80

Executive Compensation

Executive Compensation 84 Certain Relationships and Related Party Transactions 86 Principal Shareholders 87

Description of Securities

Description of Securities 88 Shares Eligible for Future Sale 92 Material U.S. Federal Tax Considerations for Non-U.S. Holders of Our Common Stock 93

Underwriting

Underwriting 96 Legal Matters 100 Experts 100 Where You Can Find More Information 100 Please read this prospectus carefully. It describes our business, financial condition, results of operations and prospects, among other things. We are responsible for the information contained in this prospectus and in any free-writing prospectus we have authorized. Neither we nor the Underwriter has authorized anyone to provide you with different information, and neither we nor the underwriter takes responsibility for any other information others may give you. Neither we nor the underwriter are making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. The information contained in this prospectus is accurate only as of the date on the front of this prospectus, regardless of the time of delivery of this prospectus or any sale of securities. You should not assume that the information contained in this prospectus is accurate as of any date other than its date. TRADEMARKS, TRADE NAMES AND SERVICE MARKS We use various trademarks, trade names and service marks in our business, including “ Biofilm Defense,” “Flura,” “Isogest;” “HempTown,” “Nu-Thera,” “HT Naturals,” “HempTown Naturals,” “Ultra Tested,” “Functional Brands,” and “Kirkman ,” among others. For convenience, we may not include the SM, ® or ™ symbols, but such omission is not meant to indicate that we would not protect our intellectual property rights to the fullest extent allowed by law. Any other trademarks, trade names or service marks referred to in this prospectus are the property of their respective owners. INDUSTRY AND MARKET DATA This prospectus includes industry data and forecasts that we obtained from industry publications and surveys, as well as public filings and internal company sources. Industry publications, surveys and

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing